Northrop Grumman (NOC) insider files to sell 7,000 shares via Fidelity
Rhea-AI Filing Summary
Northrop Grumman insider filed a notice to sell company stock under Rule 144. The filing covers 7,000 shares of common stock, to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 4,200,000.00. The notice lists 142,720,067 shares outstanding of the same class of stock.
The shares planned for sale come from restricted stock vesting awards received from the issuer as compensation. The insider acquired 4,621 shares on 02/14/2024 and 2,379 shares on 02/16/2024, both labeled as compensation. The approximate date of sale is given as 01/05/2026. By signing, the seller represents they are not aware of undisclosed material adverse information about Northrop Grumman’s operations.
Positive
- None.
Negative
- None.
FAQ
What does the latest Form 144 for NOC disclose?
The notice discloses that an insider intends to sell 7,000 shares of Northrop Grumman common stock on the NYSE, with an indicated aggregate market value of 4,200,000.00, through Fidelity Brokerage Services LLC.
When is the insider planning to sell NOC shares under this Form 144?
The filing lists an approximate sale date of 01/05/2026 for the planned sale of 7,000 shares of Northrop Grumman common stock.
How many Northrop Grumman shares are outstanding according to this Form 144?
The notice states that there are 142,720,067 shares of Northrop Grumman common stock outstanding for the class of securities involved.
How did the insider acquire the NOC shares being sold?
The shares to be sold were acquired via restricted stock vesting from the issuer as compensation: 4,621 shares on 02/14/2024 and 2,379 shares on 02/16/2024.
Which broker is handling the planned sale of NOC stock?
The Form 144 lists Fidelity Brokerage Services LLC, located in Smithfield, RI, as the broker for the planned sale of Northrop Grumman common shares on the NYSE.
What representation does the insider make in this NOC Form 144 filing?
By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about Northrop Grumman’s current or prospective operations that has not been publicly disclosed.